Sustained low-efficiency dialysis with regional citrate anticoagulation is a suitable therapeutic option for refractory hypermagnesemia in critically ill patients with AKI-Reference-Cited by-同舟云学术

Sustained low-efficiency dialysis with regional citrate anticoagulation is a suitable therapeutic option for refractory hypermagnesemia in critically ill patients with AKI

Published:2024-02-06 Issue:4 Volume:37 Page:1171-1174
ISSN:1724-6059
Container-title:Journal of Nephrology
language:en
Short-container-title:J Nephrol

Author:

Menegazzo Brenda,Regolisti Giuseppe,Greco Paolo,Maccari Caterina,Lieti Giulia,Delsante Marco,Fiaccadori Enrico,Di Mario Francesca

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s40620-023-01837-z.pdf

Reference9 articles.

1. Aal-Hamad AH, Al-Alawi AM, Kashoub MS, Falhammar H (2023) Hypermagnesemia in Clinical Practice. Medicina (Kaunas) 59(7):1190. https://doi.org/10.3390/medicina59071190

2. Pistolesi V, Morabito S, Pota V et al (2023) Regional citrate anticoagulation (RCA) in critically ill patients undergoing renal replacement therapy (RRT): expert opinion from the SIAARTI-SIN joint commission. J Anesth Analg Crit Care 3(1):7. https://doi.org/10.1186/s44158-023-00091-w

3. de Baaij JH, Hoenderop JG, Bindels RJ (2015) Magnesium in man: implications for health and disease. Physiol Rev 95(1):1–46. https://doi.org/10.1152/physrev.00012.2014

4. Van Laecke S (2019) Hypomagnesemia and hypermagnesemia. Acta Clin Belg 74(1):41–47. https://doi.org/10.1080/17843286.2018.1516173

5. Di Mario F, Regolisti G, Greco P et al (2021) Prevention of hypomagnesemia in critically ill patients with acute kidney injury on continuous kidney replacement therapy: the role of early supplementation and close monitoring. J Nephrol 34(4):1271–1279. https://doi.org/10.1007/s40620-020-00864-4